Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 205879

Expand all

INVOKAMET XR (CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE)
50MG;500MG
Marketing Status: Prescription
Active Ingredient: CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Proprietary Name: INVOKAMET XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 50MG;500MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N205879
Product Number: 001
Approval Date: Sep 20, 2016
Applicant Holder Full Name: JANSSEN PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
INVOKAMET XR (CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE)
50MG;1GM
Marketing Status: Prescription
Active Ingredient: CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Proprietary Name: INVOKAMET XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 50MG;1GM
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N205879
Product Number: 002
Approval Date: Sep 20, 2016
Applicant Holder Full Name: JANSSEN PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
INVOKAMET XR (CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE)
150MG;500MG
Marketing Status: Prescription
Active Ingredient: CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Proprietary Name: INVOKAMET XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 150MG;500MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N205879
Product Number: 003
Approval Date: Sep 20, 2016
Applicant Holder Full Name: JANSSEN PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
INVOKAMET XR (CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE)
150MG;1GM
Marketing Status: Prescription
Active Ingredient: CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Proprietary Name: INVOKAMET XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 150MG;1GM
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N205879
Product Number: 004
Approval Date: Sep 20, 2016
Applicant Holder Full Name: JANSSEN PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English